What are Emergent Biosolutions's profit margins?

Emergent Biosolutions (EBS) runs a 54.2% gross margin and a 15.0% operating margin, with a 9.6% net margin.

Where do Emergent Biosolutions's ratios come from?

Every ratio is computed from Emergent Biosolutions's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Emergent Biosolutions EBS Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Profitability
Gross margin	56.1%+21.4pp	34.7%+1.9pp	32.8%-5.2pp	38%—
Efficiency
Asset turnover	0.5×-0.1×	0.6×+0.2×	0.4×+0.1×	0.4×-0.2×
Liquidity
Current ratio	5×+1.3×	3.7×+2.6×	1×+0.1×	1×-2.4×
Leverage
Debt-to-equity	1.1×-0.3×	1.4×0.0×	1.4×+0.3×	1×+0.5×
Per Share
Book value per share	$9.22+1.2%	$9.11-28.2%	$12.68-54.2%	$27.70-7.0%
Valuation
Market capitalization	$411.74M+22.0%	$518M+316%	$124.52M-78.9%	$589.18M-74.8%
Price / sales	0.6×+0.3×	0.5×+0.4×	0.1×-0.4×	0.5×-0.8×
Price / book	0.8×+0.2×	1.1×+0.9×	0.2×-0.2×	0.4×-1.0×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Emergent Biosolutions.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Emergent Biosolutions's profit margins?: Emergent Biosolutions (EBS) runs a 54.2% gross margin and a 15.0% operating margin, with a 9.6% net margin.
Where do Emergent Biosolutions's ratios come from?: Every ratio is computed from Emergent Biosolutions's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.